Australian Medtech Access: New Report & Perceptions

by Grace Chen

Australians Face Growing Disconnect Between Expected and Actual Access to Medical Technology

Australians overwhelmingly believe their private health insurance grants them access to the latest medical technology (Medtech), but a new report reveals a significant gap between perception and reality. Released on October 28, 2025, by Johnson & Johnson MedTech, the study – titled ‘Australians on Medical Technology and the Future of Healthcare 2025’ – highlights a growing concern that the Australian healthcare system is failing to deliver on the promise of innovation.

The “Disconnect” in Medtech Access

The report, based on a nationally representative survey conducted between August and September 2025, exposes a stark “disconnect” between what Australians believe they can access with private health insurance and what they actually can. Despite a widespread view that Medtech is crucial for improving healthcare outcomes, more than 40% of respondents feel the system is falling short in providing access to technologies that could enhance care and efficiency.

This sentiment is particularly concerning given that 86% of Australians assume private health insurance provides equal or greater access to the latest advancements in medical technology. The survey further indicates that 44% of individuals would reconsider the value of their private health insurance if cutting-edge technologies were available in public hospitals but not private facilities.

Bureaucratic Delays Hamper Innovation

According to a company release, Sarah Najdek, Managing Director, Australia and New Zealand, Johnson & Johnson MedTech, emphasized that “Australians believe access to Medtech innovation is fundamental to our world-class healthcare system.” While hospitals are actively investing in innovative solutions – including robotic-assisted surgery – a key bottleneck lies in the regulatory process.

The process for listing medical devices on the Prescribed List of Medical Devices and Human Tissues Products, which dictates which products private health insurers are obligated to cover, can create substantial delays. In some instances, Australians seeking care in private hospitals may wait years after patients in public hospitals to receive access to these same innovations.

Healthcare Priorities and Diminishing Optimism

The report also sheds light on Australians’ broader healthcare priorities. Quality of care ranks among the top three concerns for citizens, surpassed only by the general cost of living and rivaling anxieties surrounding housing affordability.

However, optimism regarding the future of healthcare is waning. Fewer than half of Australians express a positive outlook, and this sentiment is even more pronounced in regional communities and among those without private health insurance. This suggests a growing sense of unease about the long-term sustainability and accessibility of quality healthcare in Australia.

.

The findings underscore the urgent need for a streamlined and equitable system for evaluating and implementing new medical technologies to ensure all Australians benefit from advancements in healthcare.

Leave a Comment